Exercise longevity evidence is endpoint-specific, not a universal hard-outcome claim

One-sentence thesis

Across the current exercise receipt bundle, the strongest longevity-relevant signal is not a universal mortality claim; it is an endpoint split: exercise and prehabilitation repeatedly improve functional capacity, blood pressure, glucose, or pulmonary-complication proxies, while hard-outcome mortality and postoperative-complication effects remain less certain in adjacent clinical populations.

Interpretation note: This is a hypothesis-generating alpha memo, not confirmatory evidence; it should not be read as a general claim that exercise extends lifespan in every population.

Why this is surprising

The practical anti-aging claim is narrower than the public-health slogan. The receipts support functional and cardiometabolic movement more directly than they support a clean hard-outcome longevity endpoint. That matters because longevity writers often collapse VO2, walking distance, blood pressure, glucose, complications, and mortality into one broad “exercise works” bucket.

Evidence receipts

• Preoperative exercise training in major-surgery adults increased peak oxygen uptake by +2 ml/kg/min (99% CI, 0.3 to 3.7) and was associated with fewer postoperative pulmonary complications (RR 0.52; 95% CI, 0.41 to 0.66). DOI 10.1513/annalsats.202002-183oc.
• Multimodal prehabilitation before abdominal cancer surgery improved 6-minute walk distance by 33.09 metres (95% CI, 17.69 to 48.50), while the postoperative-complication estimate was not significant (OR 0.81; 95% CI, 0.55 to 1.18). DOI 10.3389/fsurg.2021.628848.
• Exercise-based cardiac rehabilitation after heart-valve surgery had an imprecise mortality estimate (RR 0.83; 95% CI, 0.26 to 2.68). DOI 10.1002/14651858.cd010876.pub3.
• Exercise-based cardiac rehabilitation for coronary heart disease likely produced only a slight all-cause mortality reduction with confidence interval crossing 1.0 (RR 0.87; 95% CI, 0.73 to 1.04). DOI 10.1002/14651858.cd001800.pub4.
• In older-vs-younger comparisons, exercise plus amino-acid nutrition did not erase age-related anabolic-resistance uncertainty; only 2 of 10 combined-intervention arms provided sufficient evidence. DOI 10.1152/ajpendo.00213.2016.

What this changes

For longevity triage, exercise should be routed as an endpoint-specific intervention lane. Functional-capacity and cardiometabolic receipts are stronger candidates for near-term alpha memos than broad mortality or biological-age claims unless the next extraction binds those harder endpoints directly.

What would weaken this

• A same-population, same-endpoint receipt set showing consistent mortality or complication benefit would collapse the endpoint-split framing.
• A source audit showing the functional-capacity receipts are not comparable across surgical, cardiac, hypertensive, diabetic, and sarcopenia populations would narrow the claim further.
• A stronger biological-age or frailty endpoint bundle could supersede this clinical-endpoint framing.

Bottom line

The publishable alpha is the boundary: exercise has strong functional and cardiometabolic signals in the current bundle, but the longevity memo should not overclaim hard-outcome or anti-aging generality from those receipts.